Bharat Book Bureau

HTML clipboardBreast Cancer Drugs: World Market Prospects 2010-2025

How will expanding patient populations, improved diagnosis and new treatments benefit this market?

The breast cancer treatments market generated pharmaceutical revenues of over $11bn worldwide in 2009. The incidence and prevalence of breast cancer have been rising worldwide, in line with ageing populations, lifestyle/environmental factors and improvements in diagnosis. Expanding patient populations worldwide offer significant commercial and therapeutic opportunities, which our new report forecasts and discusses. Governments and other healthcare providers are investing in health education, diagnosis and treatments for this serious – but controllable – disorder. ( )

As Breast Cancer Drugs: World Market Prospects 2010-2025 shows, breast cancer treatment is prominent in the healthcare sector. Which segments of the breast cancer market will grow fastest in years to come? How will the industry cope with patent expiry? What are the therapeutic and commercial trends to watch? How will national markets perform from 2010 to 2025? What will happen to the current leading products and drug classes? Our new report covers those and other questions, providing the information that you need.

We predict that the global market for breast cancer drugs will expand from 2010 onwards, driven by significant prevalence of the disease in developed and developing countries. National markets for those products will expand at different rates, as will different treatment forms. The market will depend upon newer, more-effective products for its success. Our report shows how technologies that increase clinical effectiveness, safety and ease of use will be crucial therapeutically and commercially, benefiting healthcare stakeholders in breast cancer treatment.

Detailed analysis of the breast cancer disorders industry and market

Breast Cancer Drugs: World Market Prospects 2010-2025 examines that sector through a comprehensive review of information sources. We harness both primary and secondary research. This report provides unique sales forecasts, market share analyses, discussions of the R&D pipeline and analyses of commercial drivers and restraints, including a SWOT analysis. There are over 40 tables and 30 figures included, as well as three full interviews with experts. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.

For more information kindly visit :

Related Reports

Global Breast Cancer Drugs market 2009-2013

Cancer Breast Cancer Therapy Area Pipeline Report


Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Follow us on twitter:
Please visit our blog at

Author :